Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
JMIR Research Protocols|December 24, 2025
Correction: An Integrated Virtual Reality-Based Telerehabilitation Platform to Support Recovery and Maintenance of Functional Abilities Among Older Adults: Protocol for a Usability and Acceptability StudyMarco Benadduci, Claudia Franceschetti, Rachele Alessandra Marziali, et al.
JMIR Research Protocols|July 29, 2025
An Integrated Virtual Reality-Based Telerehabilitation Platform to Support Recovery and Maintenance of Functional Abilities Among Older Adults: Protocol for a Usability and Acceptability StudyMarco Benadduci, Claudia Franceschetti, Rachele Alessandra Marziali, et al.
Gait & Posture|April 14, 2017
Concurrent validation of an index to estimate fall risk in community dwelling seniors through a wireless sensor insole system: A pilot studyMirko Di Rosa, Jeff M Hausdorff, Vera Stara, et al.
JMIR Mhealth and Uhealth|June 25, 2021
Usability and Acceptance of the Embodied Conversational Agent Anne by People With Dementia and Their Caregivers: Exploratory Study in Home Environment SettingsVera Stara, Benjamin Vera, Daniel Bolliger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 14, 2011
Prognostic stratification of elderly patients in the emergency department: a comparison between the "Identification of Seniors at Risk" and the "Silver Code"Mauro Di Bari, Fabio Salvi, Anna T Roberts, et al.
The Prostate|September 30, 2014
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamideVincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, et al.
Pharmacological Research|June 22, 2005
Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cellsSalvatore Pasquale Prete, Lorena Rossi, Pier Paolo Correale, et al.
The International Journal of Biological Markers|March 9, 2016
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abirateroneSamanta Salvi, Valentina Casadio, Salvatore Luca Burgio, et al.
Endocrine-Related Cancer|April 18, 2014
Chromogranin A predicts outcome in prostate cancer patients treated with abirateroneSalvatore Luca Burgio, Vincenza Conteduca, Cecilia Menna, et al.
Frontiers in Neurology|August 29, 2022
An integrated intervention of computerized cognitive training and physical exercise in virtual reality for people with Alzheimer's disease: The jDome study protocolElena Gambella, Arianna Margaritini, Marco Benadduci, et al.
Pageof 5